Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →
| Demonstração de resultados | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receita total | $13.8B | $13.6B | $12.8B | $12.1B | $11.6B | $11.6B | $11.6B | $11.4B | $11.4B | $10.9B | $14.7B | $13.8B | $12.8B | $11.8B | $8.2B | $6.8B | $6.4B | $6.1B | $5.7B | $5.3B | $4.9B |
| Lucro bruto | $4.3B | $3.7B | $4.2B | $3.8B | $3.4B | $3.6B | $3.6B | $3.5B | $3.2B | $3.2B | $3.3B | $3.1B | $3.7B | $3.6B | $2.6B | $2.1B | $1.8B | $1.9B | $1.7B | $1.7B | $1.5B |
| Margem Bruta % | 31.1% | 27.0% | 32.9% | 31.5% | 29.3% | 31.4% | 30.8% | 30.5% | 28.1% | 29.8% | 22.2% | 22.7% | 28.7% | 30.3% | 31.8% | 30.9% | 27.8% | 30.4% | 30.7% | 31.8% | 30.5% |
| Resultado Operacional (EBIT) | $2.1B | $2.0B | $2.1B | $1.6B | $1.3B | $1.8B | $1.7B | $1.6B | $1.5B | $1.8B | $2.0B | $1.1B | $1.8B | $1.6B | $1.3B | $1.2B | $994M | $940M | $869M | $862M | $739M |
| % de margem operacional | 15.0% | 14.7% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | 16.7% | 13.8% | 8.2% | 14.2% | 13.2% | 15.8% | 17.0% | 15.4% | 15.4% | 15.3% | 16.4% | 15.2% |
| Resultado líquido | $781M | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | $270M | $723M | $633M | $536M | $478M | $406M | $423M | $374M | $382M | $290M |
| Margem Líquida % | 5.7% | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | 6.1% | 6.0% | 2.0% | 5.7% | 5.4% | 6.6% | 7.0% | 6.3% | 6.9% | 6.6% | 7.2% | 5.9% |
| EBITDA | $2.7B | $2.6B | $2.7B | $2.3B | $2.1B | $2.5B | $2.3B | $2.3B | $2.1B | $2.6B | $2.8B | $1.7B | $2.3B | $2.1B | $1.6B | $1.4B | $1.2B | $1.2B | $1.1B | $1.1B | $913M |
| Lucro por ação (EPS) | $10.14 | $8.48 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | $1.25 | $3.33 | $2.95 | $2.74 | $2.48 | $1.97 | $2.03 | $1.77 | $1.78 | $1.37 |
| Ações em circulação (M) | 69M | 88M | 87M | 93M | 96M | 110M | 123M | 154M | 172M | 191M | 205M | 216M | 217M | 215M | 196M | 193M | 206M | 208M | 212M | 215M | 212M |
Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.
Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de DVA. /companies/us/DVA
As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.
About TickerBase · Data methodology & sources · Privacy · Terms